Acasti Announces Definitive Agreement to Acquire Grace Therapeutics, Inc.

Acasti Pharma Inc.
3009 Boul. de la Concorde E.
Suite 102
Laval, Québec, Canada H7E 2B5

Jan D'Alvise
Chief Executive Officer
Phone: +1 450.686.4555
Fax: +1 450.686.2505
Email: info@acastipharma.com

Investor Relations
Crescendo Communications, LLC
Phone: 212.671.1020
Email: ACST@crescendo-ir.com

Contact